Multi-biomarker sensing
Research into electrochemical approaches that may help measure clinically relevant biomarkers and provide richer diagnostic information.
Next-generation medical diagnostics
Advancing earlier detection.
Enabling better care.
Wear.Health is developing innovative biosensor technologies designed to bring meaningful health insights closer to patients and clinicians—when decisions matter most.
Science-ledPatient-centeredBuilt for tomorrow
Health
insights
insights
Biomarker sensing
Earlier detection
Continuous monitoring
Purpose & vision
Technology driven by science. Inspired by people.
We are working toward a future where actionable diagnostic information is more timely, portable, and accessible—supporting better decisions across clinical and community settings.
FactualGrounded in research and evidence.
CaringFocused on the people behind each result.
InnovativeExploring what's possible in biosensing.
Our mission is to empower healthcare organizations and clinicians with innovative diagnostic solutions that advance patient well-being and reduce the burden of disease.
Our approach
A connected vision for diagnostic innovation.
Our development approach connects promising electrochemical sensing research with practical clinical needs and a long-term vision for monitoring.
Point-of-care diagnostics
Exploring portable testing concepts intended to support informed decisions in clinics, hospitals, and other care environments.
Wearable monitoring
Investigating next-generation wearable sensor concepts designed to enable longitudinal insights and future personalized monitoring.
Featured development areas
One technology vision. Multiple clinical opportunities.
Wear.Health is exploring applications in metabolic health and critical-care diagnostics. The pathways below are illustrative research and product concepts, not descriptions of commercially available devices.
Development area 01 · Metabolic health
Seeing metabolic risk before it becomes more visible.
Conventional glucose-based screening can miss earlier changes in insulin regulation. Wear.Health is exploring a point-of-care approach that measures both glucose and insulin, alongside a longer-term wearable monitoring vision.
01 Point-of-care screening02 Future monitoring
Why earlier detection matters
Explore the proposed window for identifying insulin resistance before conventional glucose changes become apparent.
Development area 02 · Critical care
Making every moment count in sepsis care.
Sepsis can progress rapidly, making timely clinical evaluation essential. Wear.Health is exploring multi-biomarker sensing concepts for earlier risk assessment, with a future vision for monitoring deterioration during and after acute care.
01 Rapid risk assessment02 Future monitoring
Where earlier insight could help
Review potential clinical settings ranging from emergency departments to inpatient and post-discharge care.
The future we are building toward
Better diagnostics should reach people wherever care happens.
Our long-term vision is to support real-time, personalized monitoring and advance access to actionable health information—through thoughtful research, clinical collaboration, and rigorous validation.
The people behind the vision
Leadership & research team.
Combining expertise in bioengineering, electrochemistry, strategy, and commercialization.
Jeff Labelle, Ph.D.
Chief Technology Officer · Wear.Health
CEO · labellelabs
CEO · labellelabs
Bioengineer, researcher, and professor at Grand Canyon University. Member of the National Academy of Inventors.
Alyson Schwartz
R&D Engineer · labellelabs
B.S. in Biomedical Engineering (GCU); M.S. in Biomedical Engineering in progress (ASU). Experience in clinical sample handling, biosensors, and electrochemistry.
Dean Duncan
Chief Executive Officer · Wear.Health
MBA with 30 years of leadership experience spanning finance, corporate strategy, and business development.
Insights & education
Making complex science understandable.
We plan to share educational videos and research perspectives exploring the clinical problems we are working to address and the science behind our technology.
Educational video series
Upcoming topics may include insulin resistance, early metabolic dysfunction, sepsis risk, biosensor technology, and our approach to continuous monitoring.
Collaborate with us
Advancing diagnostics together.
Wear.Health welcomes dialogue with clinicians, research institutions, health systems, and potential strategic partners interested in advancing new diagnostic technologies.
Partnership inquiries
Contact information can be added here before publication.
Contact information can be added here before publication.